```html

Eyelid Ptosis (Drooping Eyelid) – A Patient‑Friendly Guide

Overview

Eyelid ptosis (pronounced “p‑TOE‑sis”) refers to the abnormal drooping of one or both upper eyelids. The droop can be mild—just a subtle heaviness—or severe enough to cover the pupil and impair vision. Ptosis can be present at birth (congenital) or develop later in life (acquired).

Who it affects

• All ages: congenital ptosis is seen in newborns, while acquired forms are common in adults.
• Both sexes equally, though certain causes (e.g., myasthenia gravis) are slightly more common in women.
• Prevalence estimates vary, but acquired ptosis affects roughly 2–5 % of the adult population – with prevalence rising sharply after age 60 due to levator muscle degeneration [1].

Symptoms

Symptoms may appear suddenly or progress gradually. The following list includes the most frequently reported features:

• Drooping upper eyelid – can be unilateral (one eye) or bilateral.
• Visual field loss – especially in the upper visual field; patients may notice difficulty reading or navigating stairs.
• Eye strain or fatigue – the brain compensates by raising the eyebrows.
• Head tilt – to compensate for the droop and improve vision.
• Double vision (diplopia) – uncommon, but may occur if ptosis is part of a larger neurological problem.
• Eye irritation – exposure keratitis can develop if the lid cannot close fully.
• Associated symptoms depending on cause:
  • Muscle weakness elsewhere (myasthenia gravis).
  • Pain or tenderness around the eye (orbital cellulitis, tumor).
  • Skin changes or discoloration (Hutchinson sign in melanoma).

Causes and Risk Factors

Ptosis is classified as congenital or acquired. Below are the most common etiologies.

Congenital Ptosis

• Levator palpebrae superioris muscle dysgenesis – the most frequent cause; the muscle is under‑developed or has a shortened tendon.
• Genetic syndromes – e.g., Blepharophimosis‑ptosis‑epicanthus inversus syndrome (BPES) or Myotonic dystrophy.

Acquired Ptosis

• Neurogenic causes
  • Third cranial nerve palsy (stroke, aneurysm).
  • Myasthenia gravis – fluctuating weakness, worsens with activity.
  • Horner’s syndrome – associated with unilateral sympathetic loss.
• Myogenic causes
  • Age‑related levator degeneration (senile ptosis).
  • Muscular dystrophies (e.g., oculopharyngeal muscular dystrophy).
• Aponeurotic (mechanical) ptosis
  • Stretching or dehiscence of the levator aponeurosis – typical after long‑term use of contact lenses or after blepharoplasty.
• Traumatic – direct injury to the levator muscle or its nerve.
• Inflammatory/infectious
  • Orbital cellulitis, sarcoidosis, or thyroid eye disease.
• Neoplastic – eyelid or orbital tumors that infiltrate the levator complex.
• Iatrogenic – post‑surgical complications from cataract, glaucoma, or eyelid procedures.

Risk Factors

• Advancing age (senile/aponeurotic ptosis).
• Family history of congenital ptosis or related syndromes.
• Autoimmune disorders (myasthenia gravis, thyroid disease).
• History of eye or facial trauma.
• Long‑term contact lens wear (may weaken levator aponeurosis).

Diagnosis

Accurate diagnosis hinges on a thorough history, physical examination, and targeted testing.

Clinical Examination

• Marginal Reflex Distance (MRD‑1) – distance from the corneal light reflex to the upper eyelid margin; < 2 mm suggests ptosis.
• Assessment of levator function (mm of eyelid elevation on downgaze).
• Forced‑eyelid closure test – helps differentiate neurogenic from myogenic causes.
• Observation for associated signs: pupil asymmetry, eye movement deficits, facial weakness.

Diagnostic Tests

Test	Purpose
Blood work	Screen for myasthenia gravis (acetylcholine receptor antibodies), thyroid disease, inflammatory markers.
Ice‑pack test	Improvement of ptosis after 2 min of ice suggests myasthenia gravis.
Electromyography (EMG)	Detects neuromuscular transmission defects.
Imaging (CT or MRI of orbit/brain)	Evaluates structural lesions, tumors, aneurysms, or orbital fractures.
Sleep study/polysomnography	Considered if nocturnal lagophthalmos (incomplete eyelid closure) contributes to symptoms.

Treatment Options

Treatment is individualized based on severity, underlying cause, and patient preferences.

Medical Management

• Myasthenia gravis – acetylcholinesterase inhibitors (pyridostigmine), immunosuppressants, or IVIG/plasmapheresis for acute exacerbations.
• Horner’s syndrome – treat underlying cause (e.g., tumor removal).
• Inflammatory conditions – corticosteroids or disease‑modifying agents.
• Topical lubricants for exposure keratitis when lid does not close fully.

Surgical Options

When the droop interferes with vision or causes significant cosmetic concern, surgery is the mainstay.

1. Levator resection/amendment – shortens or tightens the levator muscle; ideal for good levator function (> 4 mm).
2. Müller’s muscle‑conjunctival resection (MMCR) – less invasive; works when Müller’s muscle contributes ≥ 1 mm of lift (often effective in mild ptosis).
3. Frontalis sling (suspension) surgery – uses a silicone or autologous fascial sling to link the eyelid to the frontalis muscle; preferred for severe ptosis with poor levator function.
4. Ptosis crutches – removable eyelid supports attached to glasses; non‑surgical alternative for patients who cannot undergo surgery.

Lifestyle & Non‑Surgical Measures

• Use of artificial tears, night‑time ointments, or moisture goggles.
• Eye protection (sunglasses) in windy or dusty environments.
• Avoidance of heavy eye‑muscle strain (e.g., prolonged screen time without breaks).
• Regular follow‑up with an ophthalmologist or neurologist to monitor disease progression.

Living with Eyelid Ptosis

Even after successful treatment, many patients benefit from practical strategies to manage daily activities.

• Reading and computer work – position reading material slightly below eye level; use a bookmark or a reading strip to keep text within the clear visual field.
• Driving – ensure the upper visual field is unrestricted; if vision is impaired, discuss with a licensing authority.
• Makeup & cosmetics – opt for waterproof mascara and avoid heavy eye‑shadow on the drooping lid to reduce irritation.
• Sleep – elevate the head of the bed 6–8 inches to lessen eyelid swelling.
• Follow‑up schedule – at least annually, or sooner if symptoms change.

Prevention

While some forms (congenital, age‑related degeneration) cannot be prevented, risk of acquired ptosis can be reduced:

• Protect eyes from trauma – wear safety goggles during sports or hazardous work.
• Manage systemic diseases – keep thyroid disease, diabetes, and hypertension under control.
• Promptly treat infections or inflammatory eye conditions.
• Avoid long‑term excessive use of heavy eyelid cosmetics that may weigh the lid down.
• Regular eye examinations, especially after ocular surgery.

Complications

If left untreated, ptosis can lead to several secondary problems:

• Visual impairment – chronic upper‑field loss can affect reading, driving, and occupational tasks.
• Amblyopia (lazy eye) – especially in children where the brain suppresses input from the droopy eye.
• Exposure keratopathy – corneal drying, ulceration, or infection due to incomplete lid closure.
• Psychosocial impact – reduced self‑esteem, social anxiety, or depression.
• Progression of underlying disease – e.g., unrecognized myasthenia gravis may evolve to a myasthenic crisis.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. “Ptosis (droopy eyelid).” Accessed April 2024.
2. American Academy of Ophthalmology. “Management of Ptosis.” 2023.
3. NIH National Eye Institute. “Age‑Related Changes in the Eyelid.” 2022.
4. Cleveland Clinic. “Myasthenia Gravis – Diagnosis and Treatment.” 2024.
5. World Health Organization. “Global Prevalence of Ocular Disorders.” 2023.

```